Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RAPID MICRO BIOSYSTEMS, INC. Regulatory Filings 2021

Jul 12, 2021

33936_rns_2021-07-12_4e7f01db-3851-46fa-9d4a-9b0d91b51f82.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm

July 12, 2021

Via EDGAR Transmission

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-6010

Attention:
Laura Crotty
Jenn Do
Daniel Gordon
Re:
Registration Statement on Form S-1
Filed July 12, 2021
Registration No. 333-257431

Ladies and Gentleman:

In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on July 14, 2021, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as Rapid Micro Biosystems, Inc. (the “ Company ”) or its counsel may request via telephone call to the staff. Please contact Wesley Holmes of Latham & Watkins LLP, counsel to the Company, at (617) 948-6027, or in his absence, Jennifer Yoon at (617) 880-4540, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.

Field: Page; Sequence: 1

Field: /Page

Sincerely yours,

Rapid Micro Biosystems, Inc.

By:
Robert Spignesi
President and Chief Executive Officer
cc:
Jennifer A. Yoon, Esq.

Field: Page; Sequence: 2; Options: Last

Field: /Page